Skip to main content
. 2024 Oct 5;16(10):1300. doi: 10.3390/pharmaceutics16101300

Figure 7.

Figure 7

Figure 7

The different antioxidant activities of PHL, ZnO NPs, and ZnO-PEG-PHL NPs (A). The cell viability assay of A549 cancer cell line. The IC50 value of PHL (B), ZnO NPs (C), and ZnO-PEG-PHL NPs (D).